Long-term safety and anticonvulsant activity of add-on ganaxolone in treatment-refractory paediatric epilepsy

被引：0
|
作者：
Tsai, J. [1 ]
Pieribone, V [1 ,2 ]
Shaw, K. [1 ]
Soufflet, C.
Dulac, O.
Giller, E. [1 ]
机构：
[1] Marinus Pharmaceut Inc, Branford, CT USA
[2] John B Pierce Lab, New Haven, CT USA
来源：
EPILEPSIA | 2007年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [21] LONG-TERM EFFICACY OF LAMOTRIGINE WITH ADD-ON TRIAL IN TREATMENT-RESISTANT EPILEPSY - A BRAZILIAN EXPERIENCE
    HERNANDEZFUSTES, OJ
    DEBITTENCOURT, PRM
    EPILEPSIA, 1995, 36 : S116 - S116
  • [22] rTMS as an add-on therapeutic tool in treatment-refractory obsessive compulsive disorder
    Bencini, L.
    Cravaro, Ramella, V
    Quercioli, L.
    Di Rollo, A.
    Pallanti, S.
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2013, 2 (02) : 230 - 230
  • [23] Ziprasidone's long-term efficacy in treatment-refractory schizophrenia
    Kane, JM
    Khanna, S
    Giller, EL
    Rajadhyaksha, S
    Loebel, A
    Siu, C
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 52S - 53S
  • [24] Long-term safety and efficacy of highly purified cannabidiol for treatment refractory epilepsy
    Gaston, Tyler E.
    Ampah, Steve B.
    Bebin, E. Martina
    Grayson, Leslie P.
    Cutter, Gary R.
    Hernando, Kathleen
    Szaflarski, Jerzy P.
    EPILEPSY & BEHAVIOR, 2021, 117
  • [25] LONG-TERM OBSERVATIONS ON THE CLINICAL USE OF LAMOTRIGINE AS ADD-ON DRUG IN PATIENTS WITH EPILEPSY
    COCITO, L
    MAFFINI, M
    LOEB, C
    EPILEPSY RESEARCH, 1994, 19 (02) : 123 - 127
  • [26] Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy
    Borges, Karin
    Kaul, Neha
    Germaine, Jack
    Carrasco-Pozo, Catalina
    Kwan, Patrick
    O'Brien, Terence J.
    EPILEPSIA OPEN, 2020, 5 (02) : 230 - 239
  • [27] THE LONG-TERM SAFETY AND EFFICACY OF GABAPENTIN (NEURONTIN(R)) AS ADD-ON THERAPY IN DRUG-RESISTANT PARTIAL EPILEPSY
    OOMMEN, K
    PENRY, J
    RIELA, A
    ROWAN, A
    ROSENBAUM, D
    SCHEAR, M
    SIVAK, M
    WIENER, J
    SAUERMANN, W
    WIBBERG, M
    SMITH, D
    KRAMER, R
    YERBY, M
    LESSER, R
    FISHER, R
    SANDERS, P
    NORTH, R
    HOMAN, R
    HAYES, A
    SHELLENBERGER, MK
    TRUDEAU, V
    WALLACE, J
    SACKELLARES, J
    AASVED, K
    HIRSCHORN, K
    OLSON, L
    LEPPIK, I
    RASK, C
    ROSENFELD, W
    FROMM, GH
    NAGEL, N
    DREIFUSS, F
    BERTRAM, E
    COOPER, G
    LEE, SI
    OJEMANN, L
    WILENSKY, A
    ABOUKHALIL, B
    COURVILLE, K
    MCLEAN, M
    RAMSAY, R
    GUTERMAN, A
    MCJILTON, J
    SANCHEZ, R
    SLATER, J
    MATTSON, R
    SCHEYER, R
    TREIMAN, D
    HANDFORTH, A
    EPILEPSY RESEARCH, 1994, 18 (01) : 67 - 73
  • [28] LONG-TERM EFFICACY AND TOLERABILITY DATA ON TOPIRAMATE AS ADD-ON THERAPY IN PATIENTS WITH TREATMENT-RESISTANT EPILEPSY
    Papacostas, S.
    Dietis, A.
    Flourentzou, A.
    Stylianidou, G.
    Koukkoullis, R.
    Kkolou, E.
    EPILEPSIA, 2009, 50 : 194 - 195
  • [29] The clinical efficacy and safety of levetiracetam add-on therapy for child refractory epilepsy
    Chen, J.
    Liu, X. -M.
    Yue, X.
    Chen, S. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (12) : 2689 - 2694
  • [30] THE TOXIC EFFECTS OF ANTICONVULSANT DRUGS IN LONG-TERM TREATMENT OF EPILEPSY
    RAMANA, R
    SILVERSTONE, PH
    LISHMAN, WA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (09): : 1116 - 1116
12345